FDA Drug Application (022097) for STAVUDINE; LAMIVUDINE; EFAVIRENZ by STRIDES ACROLAB

Back to FDA Applications sponsored by STRIDES ACROLAB

Application Number022097
Product Number001
FormTABLET; ORAL
Dosage40MG; 150MG; 600MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSTAVUDINE; LAMIVUDINE; EFAVIRENZ
Active IngredientSTAVUDINE; LAMIVUDINE; EFAVIRENZ



Back to FDA Applications sponsored by STRIDES ACROLAB

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.